FTAZX
Price
$9.43
Change
-$0.01 (-0.11%)
Updated
Jun 20 closing price
Net Assets
655.05M
MPGOX
Price
$8.81
Change
-$0.00 (-0.00%)
Updated
Jun 20 closing price
Net Assets
105.97M
Interact to see
Advertisement

FTAZX vs MPGOX

Header iconFTAZX vs MPGOX Comparison
Open Charts FTAZX vs MPGOXBanner chart's image
Franklin AZ Tax Free Income A1
Price$9.43
Change-$0.01 (-0.11%)
VolumeN/A
Net Assets655.05M
MFS GA Municipal Bond R6
Price$8.81
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets105.97M
FTAZX vs MPGOX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FTAZX vs. MPGOX commentary
Jun 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FTAZX is a Hold and MPGOX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FTAZX has more cash in the bank: 655M vs. MPGOX (106M). MPGOX (3.39) and FTAZX (3.31) have matching dividends . FTAZX was incepted earlier than MPGOX: FTAZX (38 years) vs MPGOX (8 years). MPGOX (0.68) and FTAZX (0.67) have similar cost to investors . MPGOX is a more actively managed with annual turnover of: 20.00 vs. FTAZX (10.60). MPGOX has a lower initial minimum investment than FTAZX: MPGOX (0) vs FTAZX (1000). MPGOX annual gain was more profitable for investors over the last year : -0.50 vs. FTAZX (-0.85). MPGOX return over 5 years is better than : 1.97 vs. FTAZX (-4.20).
FTAZXMPGOXFTAZX / MPGOX
Total Expense Ratio0.670.60112%
Annual Report Gross Expense Ratio0.670.6899%
Fund Existence38 years8 years-
Gain YTD-2.344-2.022116%
Front Load4%N/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets655M106M618%
Annual Yield % from dividends3.313.3998%
Returns for 1 year-0.85-0.50170%
Returns for 3 years5.527.7771%
Returns for 5 years-4.201.97-213%
Returns for 10 years-2.30N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VGIFX85.110.10
+0.12%
JPMorgan US Value R5
SCAVX13.65N/A
N/A
AB Small Cap Value A
MVISX43.19N/A
N/A
Patient Opportunity IS
FISGX39.46-0.12
-0.30%
Nuveen Small/Mid Cap Growth Opp I
RYWVX69.86-1.66
-2.32%
Rydex Emerging Markets 2X Strategy H